,trastuzumab deruxtecan
astrazeneca,daiichi sankyo
['breast']
#asco22 destiny-breast 04 received a standing ovation at the plenary session! exciting data and practice changing for our #breastcancer patients! 
Hematology/Oncology Fellow @UMiamiMedicine @JacksonHealth @SylvesterCancer | Tweets are my own. ???????? #Sarcoma #BreastCancer